UBS Oconnor LLC
- SEC CIK
- 0001132716
- Latest filing
- Aug 14, 2026
HRTX holding history
Heron Therapeutics, Inc. in every 13F filed by UBS Oconnor LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
HRTX overviewAll 13F holders of HRTXFull Q4 2025 holdings
- Shares (Q3 2022)
- 0
- Sold out in Q3 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2022 | 0 | $0 | 0.0% | −10,145,000−100.0% | Sold out | Holders |
| Q2 2022 | 10,145,000 | $28.3M | 0.3% | +10,145,000 | New | Holders |
| Q1 2022 | 0 | $0 | 0.0% | −8,275,000−100.0% | Sold out | Holders |
| Q4 2021 | 8,275,000 | $75.6M | 0.7% | +1,641,084+24.7% | Added | Holders |
| Q3 2021 | 6,633,916 | $70.9M | 0.6% | +2,208,916+49.9% | Added | Holders |
| Q2 2021 | 4,425,000 | $68.7M | 0.6% | +2,100,000+90.3% | Added | Holders |
| Q1 2021 | 2,325,000 | $37.7M | 0.5% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.